Worldwide Recall On Allergan Textured Breast Implants
Executive Summary
Allergan PLC announced that it would take its Biocell textured breast implants and tissue expanders off the market worldwide shortly after the US FDA released additional information linking the use of the implants to a rare cancer.
You may also be interested in...
Judge OKs Class-Action Suit From Allergan Investors
The lawsuit says that Allergan repeatedly downplayed the cancer risk its textured breast implants posed as compared to those from other manufacturers.
FDA: 36 Dead From Breast Implant-Associated Lymphoma Since 2019, Hundreds Sickened
The US FDA reports the numbers on women globally who've died or been sickened by two types of breast implant illnesses.
FDA Issues Warning Letters To Breast Implant Makers Allergan And Ideal Implant
The US agency warned Allergan about failing to meet postmarket study requirements and Ideal Implant about Quality System Regulation violations.